Navigation Links
Affymetrix and Stratagene Announce Strategic Software Alliance

Affymetrix and Stratagene announced today that they have entered into a non-exclusive strategic alliance under which Stratagene will provide Affymetrix customers with new software solutions for GeneChip(R) data analysis. As part of this agreement, Stratagene will develop a new software package for Affymetrix, ArrayAssist(R) Lite, which will be offered as a standard statistical analysis solution of Affymetrix gene expression microarrays.

In April 2005, Affymetrix will make ArrayAssist Lite available to its existing GeneChip customers via the Internet and will also begin pre-installing the software on new GeneChip workstation desktops. Through an easy-to-use interface and tightly integrated workflow, ArrayAssist Lite will enable the application of industry-leading statistical algorithms and generation of standard Affymetrix-format data files and reports. In its first release, ArrayAssist Lite will support RMA, GC-RMA, MAS5, and also PLIER, a new advanced signal estimator developed by Affymetrix statisticians. Affymetrix customers will also be given the option of upgrading to Stratagene's ArrayAssist software, which provides advanced downstream analysis capabilities such as gene clustering, pattern detection, and interactive visualizations.

"ArrayAssist Lite software will provide highly accurate, precise and sensitive methods needed to support expression research," said Jason Goncalves, General Manager of Stratagene's software solutions business. "We've placed these capabilities in a software tool designed for life scientists, and the result will be better quality data to accelerate biological discovery and validation."

"We are very pleased to announce this expansion of our longstanding relationship with Stratagene," said Steve Lincoln, Vice-President of Informatics at Affymetrix. "The combination of our GeneChip platform and the ArrayAssist softw are makes the industry-leading methods for measuring gene expression on a genomic-scale available to an ever broadening community of life scientists."

As part of the agreement, Stratagene has joined the community of Affymetrix partners developing methods for next-generation gene expression microarrays. "Affymetrix' tiling arrays are revolutionizing functional analysis," said Dr. Joseph A. Sorge, Chairman and CEO of Stratagene. "We believe that our technology will provide key functionality needed to support important genomic studies. In addition, we're very excited to join Affymetrix' consortium of developers in an effort to bring to market breakthrough gene expression microarray technology. By partnering with other thought leaders in our field, we believe we have the opportunity to position our technology as a standard for expression analysis."



Related biology news :

1. Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering
2. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works
3. Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance
4. Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
5. Affymetrix Launches New Globin-Reduction Kits and Protocol Developed with PreAnalytiX
6. Affymetrix and bioMerieux Extend Their Agreement on GeneChip(R) Technology to Breast Cancer Diagnostics
7. Affymetrix and ParAllele Launch Industrys Most Comprehensive Product Line for Targeted Genotyping
8. Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible?status
9. Affymetrix 500K array used to identify memory gene
10. FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
11. Ariadne Genomics Announces the Release of PathwayStudio?Central, Client-Server Software for Biological Pathway Analysis
Post Your Comments:

(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... Florida , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange ... potential users of its soon to be launched online ... ( ) will also provide potential ... use of DNA technology to an industry that is ...
(Date:3/22/2016)... 22, 2016 According ... Market for Consumer Industry by Type (Image, Motion, ... (Communication & IT, Entertainment, Home Appliances, & ... to 2022", published by MarketsandMarkets, the market ... reach USD 26.76 Billion by 2022, at ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
Breaking Biology Technology: